Likewise, Todaro et al. (2013) have demonstrated that breast cancer stem-like cells isolated from tumor tissues express the EPOR and respond to EPO treatment with increased proliferation and resistance to chemotherapeutic agents. This evidence concerns the gene EPOR and breast cancer.